Your browser doesn't support javascript.
loading
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.
Papakonstantinou, Nikos; Ntoufa, Stavroula; Tsagiopoulou, Maria; Moysiadis, Theodoros; Bhoi, Sujata; Malousi, Andigoni; Psomopoulos, Fotis; Mansouri, Larry; Laidou, Stamatia; Papazoglou, Despoina; Gounari, Maria; Pasentsis, Konstantinos; Plevova, Karla; Kuci-Emruli, Venera; Duran-Ferrer, Marti; Davis, Zadie; Ek, Sara; Rossi, Davide; Gaidano, Gianluca; Ritgen, Matthias; Oscier, David; Stavroyianni, Niki; Pospisilova, Sarka; Davi, Frederic; Ghia, Paolo; Hadzidimitriou, Anastasia; Belessi, Chrysoula; Martin-Subero, Jose I; Pott, Christiane; Rosenquist, Richard; Stamatopoulos, Kostas.
Afiliação
  • Papakonstantinou N; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Ntoufa S; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Tsagiopoulou M; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Moysiadis T; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Bhoi S; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Malousi A; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Psomopoulos F; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Mansouri L; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Laidou S; Laboratory of Biological Chemistry, Medical School, Aristotle University of Thessaloniki, Greece.
  • Papazoglou D; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Gounari M; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Pasentsis K; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Plevova K; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Kuci-Emruli V; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Duran-Ferrer M; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Davis Z; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Ek S; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Rossi D; Center of Molecular Biology and Gene Therapy, Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Medical Faculty of the Masaryk University, Brno, Czech republic.
  • Gaidano G; Department of Immunotechnology, Faculty of Engineering, Lund University, Sweden.
  • Ritgen M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Departamento de Fundamentos Clínicos, Universitat de Barcelona, Barcelona, Spain.
  • Oscier D; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Stavroyianni N; Department of Immunotechnology, Faculty of Engineering, Lund University, Sweden.
  • Pospisilova S; Hematology, Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland.
  • Davi F; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Ghia P; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Hadzidimitriou A; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Belessi C; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Martin-Subero JI; Center of Molecular Biology and Gene Therapy, Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Medical Faculty of the Masaryk University, Brno, Czech republic.
  • Pott C; Hematology Department and University Pierre et Marie Curie, Paris, France.
  • Rosenquist R; Division of Experimental Oncology, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute and Università Vita-Salute San Raffaele, Milan, Italy.
  • Stamatopoulos K; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
Int J Cancer ; 144(11): 2695-2706, 2019 06 01.
Article em En | MEDLINE | ID: mdl-30447004
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Receptores de Antígenos de Linfócitos B / Leucemia Linfocítica Crônica de Células B / Regulação Neoplásica da Expressão Gênica / Metilação de DNA / Proteínas Supressoras de Tumor Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Int J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Grécia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Receptores de Antígenos de Linfócitos B / Leucemia Linfocítica Crônica de Células B / Regulação Neoplásica da Expressão Gênica / Metilação de DNA / Proteínas Supressoras de Tumor Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Int J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Grécia País de publicação: Estados Unidos